BioCeramic Therapeutics (United Kingdom) a development-stage provider of bioactive materials for orthopaedic and dental applications, closed a $1.9M Series B financing. Participants include Imperial Innovations, Longbow Capital Partners, Comvest and Esmee Fairbairn Foundation.

Note: 2009 Year-in-Review Trend Analysis Coming 15 Feb.